BBI Solutions (BBI) today announced the launch of SCIPAC Clinical Specimen Panels. SCIPAC are quantitative panels of clinical specimen, collected from multiple donors of known genotype. Panels currently available from BBI include the SCIPAC range of Hepatitis, HIV and Syphilis.
Adding to BBI’s extensive biobank portfolio, the panels provide a quantity of trusted patient samples to diagnostic companies and academic researchers. These will assist research and development and QC departments with their quality control testing to assess proof of concept experiments when developing new assays for infectious diseases.